Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure
Clinical trial NCT02151383 · TERMINATED
Trial details
- NCT number
- NCT02151383
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-05
- Primary completion
- 2017-04-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.